Immunodeficiency: A Protective Factor for COVID-19?

被引:1
作者
AlShanableh, Zain [1 ]
Haidous, Mohammad [1 ]
Wong, Krista M. [1 ]
Al-Saed, Mohamad [1 ]
Altaqi, Basel [1 ]
机构
[1] St Vincent Char Med Ctr, Internal Med, Cleveland, OH 44115 USA
关键词
ards; cytokine storm; cd4+ lymphocytopenia; immunodeficiency; covid-19;
D O I
10.7759/cureus.23094
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coronavirus disease 2019 (COVID-19) is an infection that involves the respiratory tract and is attributed to severe acute respiratory syndrome coronavirus 2. While most people develop mild or uncomplicated illness, approximately 15% develop a severe disease that requires oxygen support, and 5% develop a critical disease. While immunodeficiency is reported as a risk factor for COVID-19, we present a patient with idiopathic CD4+ lymphocytopenia who developed severe COVID-19 with an unexpected clinical course and complete recovery.
引用
收藏
页数:4
相关论文
共 8 条
[1]   Dexamethasone for the Treatment of Coronavirus Disease (COVID-19): a Review [J].
Mukhtar H. Ahmed ;
Arez Hassan .
SN Comprehensive Clinical Medicine, 2020, 2 (12) :2637-2646
[2]  
Alhazzani W, 2020, CRIT CARE MED, V48, pE440, DOI [10.1007/s00134-020-06022-5, 10.1097/CCM.0000000000004363]
[3]  
[Anonymous], 2017, EFFECTS CYTOKINES T
[4]   A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia [J].
Quinti, Isabella ;
Lougaris, Vassilios ;
Milito, Cinzia ;
Cinetto, Francesco ;
Pecoraro, Antonio ;
Mezzaroma, Ivano ;
Mastroianni, Claudio Maria ;
Turriziani, Ombretta ;
Bondioni, Maria Pia ;
Filippini, Matteo ;
Soresina, Annarosa ;
Spadaro, Giuseppe ;
Agostini, Carlo ;
Carsetti, Rita ;
Plebani, Alessandro .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 146 (01) :211-+
[5]   Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover [J].
Soresina, Annarosa ;
Moratto, Daniele ;
Chiarini, Marco ;
Paolillo, Ciro ;
Baresi, Giulia ;
Foca, Emanuele ;
Bezzi, Michela ;
Baronio, Barbara ;
Giacomelli, Mauro ;
Badolato, Raffaele .
PEDIATRIC ALLERGY AND IMMUNOLOGY, 2020, 31 (05) :565-569
[6]  
World Health Organization, 2021, GUIDANCE
[7]  
Yang X, 2020, LANCET RESP MED, V8, pE26
[8]   The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China [J].
Zhang, Wen ;
Zhao, Yan ;
Zhang, Fengchun ;
Wang, Qian ;
Li, Taisheng ;
Liu, Zhengyin ;
Wang, Jinglan ;
Qin, Yan ;
Zhang, Xuan ;
Yan, Xiaowei ;
Zeng, Xiaofeng ;
Zhang, Shuyang .
CLINICAL IMMUNOLOGY, 2020, 214